Bank of New York Mellon’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,434
| Closed | -$45K | – | 4543 |
|
|
2023
Q1 | $45K | Hold |
17,434
| – | – | ﹤0.01% | 4210 |
|
|
2022
Q4 | $29.3K | Buy |
17,434
+3
| +0% | +$17 | ﹤0.01% | 4311 |
|
|
2022
Q3 | $187K | Hold |
17,431
| – | – | ﹤0.01% | 4046 |
|
|
2022
Q2 | $285K | Sell |
17,431
-118
| -0.7% | -$2.26K | ﹤0.01% | 3912 |
|
|
2022
Q1 | $444K | Buy |
17,549
+15,221
| +654% | +$321K | ﹤0.01% | 3785 |
|
|
2021
Q4 | $49K | Hold |
2,328
| – | – | ﹤0.01% | 4506 |
|
|
2021
Q3 | $109K | Buy |
+2,328
| New | +$118K | ﹤0.01% | 4322 |
|
|
2019
Q2 | – | Sell |
-243
| Closed | -$30K | – | 4354 |
|
|
2019
Q1 | $30K | Sell |
243
-213
| -47% | -$29.1K | ﹤0.01% | 4131 |
|
|
2018
Q4 | $64K | Buy |
456
+378
| +485% | +$95K | ﹤0.01% | 4030 |
|
|
2018
Q3 | $24K | Hold |
78
| – | – | ﹤0.01% | 4199 |
|
|
2018
Q2 | $24K | Hold |
78
| – | – | ﹤0.01% | 4160 |
|
|
2018
Q1 | $32K | Buy |
78
+29
| +59% | +$11.9K | ﹤0.01% | 4233 |
|
|
2017
Q4 | $18K | Buy |
49
+2
| +4% | +$701 | ﹤0.01% | 4309 |
|
|
2017
Q3 | $10K | Sell |
47
-6
| -11% | -$1.34K | ﹤0.01% | 4242 |
|
|
2017
Q2 | $14K | Buy |
53
+1
| +2% | +$245 | ﹤0.01% | 4252 |
|
|
2017
Q1 | $15K | Hold |
52
| – | – | ﹤0.01% | 4239 |
|
|
2016
Q4 | $15K | Buy |
52
+3
| +6% | +$1.03K | ﹤0.01% | 4233 |
|
|
2016
Q3 | $19K | Sell |
49
-21
| -30% | -$8.04K | ﹤0.01% | 4222 |
|
|
2016
Q2 | $25K | Buy |
70
+11
| +19% | +$4.63K | ﹤0.01% | 4254 |
|
|
2016
Q1 | $33K | Sell |
59
-5
| -8% | -$2.13K | ﹤0.01% | 4132 |
|
|
2015
Q4 | $34K | Buy |
64
+5
| +8% | +$3.76K | ﹤0.01% | 4236 |
|
|
2015
Q3 | $67K | Buy |
+59
| New | +$77.3K | ﹤0.01% | 4205 |
|
Bank of New York Mellon's ONCS Position: Q2 2023 in Review
Bank of New York Mellon sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 17,434 shares — an estimated $45K sold.
Bank of New York Mellon first reported a position in ONCS in Q3 2015 and held it in 22 quarters. The position peaked at $444K in Q1 2022. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.
- Bank of New York Mellon reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
- Bank of New York Mellon sold 17,434 OncoSec Medical Incorporated shares in Q2 2023, an estimated $45K.
- Bank of New York Mellon first reported a position in OncoSec Medical Incorporated in Q3 2015 and held it in 22 quarters.
- Bank of New York Mellon's OncoSec Medical Incorporated position peaked at $444K in Q1 2022.
- 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.